{
    "topic": "materials defects",
    "links_count": 12,
    "title": "Infinity Research on Materials defects: Multi\u2011source Synthesis and Semantic Routes",
    "value_usd": 822,
    "research": "\u001b[93mInfinity\u001b[0m \u001b[93mResearch\u001b[0m on \u001b[93mMaterials\u001b[0m \u001b[93mdefects\u001b[0m: \u001b[93mMulti\u001b[0m\u2011\u001b[94msource\u001b[0m \u001b[93mSynthesis\u001b[0m and \u001b[93mSemantic\u001b[0m \u001b[91mRoutes\u001b[0m\n\n\u001b[92mEngineer:\u001b[0m Core constructs across d/p/f blocks and systems design.\n\u001b[93mResearch:\u001b[0m Aggregated findings from 12 sources with quantitative signals.\n\u001b[95mAssimilate:\u001b[0m Integrated correlations: electronegativity, ionization, radius, redox.\n\u001b[91mRoutes:\u001b[0m Emerging pathways, anomalies, and catalytic variants.\n\u001b[95mInvestigate:\u001b[0m Audits, validations, and discrepancy probes.\n\u001b[94mImport:\u001b[0m Inputs synthesized from harvested links (kept in hashes).\n\u001b[33mCEO:\u001b[0m Anchoring token in Infinity ledger for governance.\n\n\n- \u001b[93mDefects\u001b[0m in \u001b[93mmultilayer\u001b[0m \u001b[93mplastic\u001b[0m \u001b[93mfilms\u001b[0m \u001b[93mI\u001b[0m: \u001b[92mInterface\u001b[0m \u001b[93mdefects\u001b[0m in \u001b[93mextrusion\u001b[0m\n- \u001b[93mExtended\u001b[0m \u001b[93mDefects\u001b[0m in \u001b[93mSemiconductors\u001b[0m\n- \u001b[93mSensor\u001b[0m \u001b[93mfilm\u001b[0m \u001b[93mminimizes\u001b[0m \u001b[93mdefects\u001b[0m\n- \u001b[93mTailoring\u001b[0m \u001b[93mcarbon\u001b[0m-\u001b[93mbased\u001b[0m \u001b[93mnanozymes\u001b[0m without \u001b[93mmetal\u001b[0m \u001b[93mcofactors\u001b[0m: \u001b[92mDesign\u001b[0m \u001b[93mprinciples\u001b[0m and \u001b[93mapplications\u001b[0m \u001b[93macross\u001b[0m \u001b[93mtherapeutics\u001b[0m and \u001b[93msensing\u001b[0m.: \u001b[93mMetal\u001b[0m-\u001b[93mfree\u001b[0m \u001b[93mnanozymes\u001b[0m (\u001b[93mMFNs\u001b[0m), \u001b[93mcomposed\u001b[0m of \u001b[93mheteroatom\u001b[0m-\u001b[93mdoped\u001b[0m \u001b[93mcarbon\u001b[0m \u001b[93mframeworks\u001b[0m, \u001b[93mconductive\u001b[0m \u001b[93mpolymers\u001b[0m, and \u001b[93m\u03c0\u001b[0m-\u001b[93mconjugated\u001b[0m \u001b[93mnetworks\u001b[0m, \u001b[93mhave\u001b[0m \u001b[93memerged\u001b[0m as \u001b[93mversatile\u001b[0m \u001b[93menzyme\u001b[0m \u001b[93mmimics\u001b[0m that \u001b[93mobviate\u001b[0m the \u001b[93mtoxicity\u001b[0m and \u001b[93minstability\u001b[0m \u001b[93massociated\u001b[0m with \u001b[93mmetal\u001b[0m-\u001b[93mbased\u001b[0m \u001b[93mcounterparts\u001b[0m. Through the \u001b[93mstrategic\u001b[0m \u001b[93mincorporation\u001b[0m of \u001b[93mnitrogen\u001b[0m (\u001b[93mN\u001b[0m), \u001b[93moxygen\u001b[0m (\u001b[93mO\u001b[0m), \u001b[93msulfur\u001b[0m (\u001b[93mS\u001b[0m), \u001b[93mphosphorus\u001b[0m (\u001b[93mP\u001b[0m), \u001b[93miodine\u001b[0m (\u001b[93mI\u001b[0m), and \u001b[93mselenium\u001b[0m (\u001b[93mSe\u001b[0m) \u001b[93mdopants\u001b[0m, \u001b[93malongside\u001b[0m the \u001b[93mdeliberate\u001b[0m \u001b[93mdefect\u001b[0m \u001b[92mengineering\u001b[0m of \u001b[93msp\u00b2\u001b[0m \u001b[93mdomains\u001b[0m and \u001b[93mvacancy\u001b[0m \u001b[93msites\u001b[0m, these \u001b[93mmaterials\u001b[0m \u001b[93mreplicates\u001b[0m \u001b[93msuperoxide\u001b[0m \u001b[93mdismutase\u001b[0m, \u001b[93mglutathione\u001b[0m \u001b[93mperoxidase\u001b[0m, \u001b[93mcatalase\u001b[0m, \u001b[93moxidase\u001b[0m, and \u001b[93mperoxidase\u001b[0m \u001b[93mactivities\u001b[0m under \u001b[93mphysiological\u001b[0m and \u001b[93menvironmental\u001b[0m \u001b[93mconditions\u001b[0m. This \u001b[93mreview\u001b[0m not only \u001b[93moutlines\u001b[0m the \u001b[93mstructural\u001b[0m \u001b[92mdesign\u001b[0m \u001b[93mprinciples\u001b[0m and \u001b[93mcatalytic\u001b[0m \u001b[93mmechanisms\u001b[0m of \u001b[93mMFNs\u001b[0m but \u001b[93malso\u001b[0m \u001b[93mpresents\u001b[0m a \u001b[93mcomparative\u001b[0m \u001b[93manalysis\u001b[0m with \u001b[93mtraditional\u001b[0m \u001b[93mmetal\u001b[0m-\u001b[93mbased\u001b[0m \u001b[93mnanozymes\u001b[0m, \u001b[93mhighlighting\u001b[0m \u001b[93mdifferences\u001b[0m in \u001b[93mcatalytic\u001b[0m \u001b[91mpathways\u001b[0m, \u001b[93mstability\u001b[0m, and \u001b[93mbiocompatibility\u001b[0m. \u001b[93mRecent\u001b[0m \u001b[93mstudies\u001b[0m are \u001b[93msystematically\u001b[0m \u001b[93mcategorized\u001b[0m into \u001b[93mfour\u001b[0m \u001b[93mmajor\u001b[0m \u001b[93mapplication\u001b[0m \u001b[93mdomains\u001b[0m-\u001b[93mantioxidant\u001b[0m \u001b[93mtherapeutics\u001b[0m, \u001b[93mtumor\u001b[0m-\u001b[93mtargeted\u001b[0m \u001b[93mcatalytic\u001b[0m \u001b[93mtherapy\u001b[0m, \u001b[93mdiagnostic\u001b[0m and \u001b[93mbiosensing\u001b[0m \u001b[92mplatforms\u001b[0m, \u001b[93mantimicrobial\u001b[0m \u001b[92msystems\u001b[0m, and \u001b[93menvironmental\u001b[0m \u001b[93mremediation\u001b[0m-\u001b[93mshowcasing\u001b[0m \u001b[93mrepresentative\u001b[0m \u001b[93mexamples\u001b[0m \u001b[93msuch\u001b[0m as \u001b[93mbiomass\u001b[0m-\u001b[93mderived\u001b[0m \u001b[93mcarbon\u001b[0m \u001b[93mdots\u001b[0m, \u001b[93mpolyphenol\u001b[0m-\u001b[93mfunctionalized\u001b[0m \u001b[93mnanoparticles\u001b[0m, \u001b[93msingle\u001b[0m-\u001b[93matom\u001b[0m \u001b[93mcatalysts\u001b[0m, \u001b[93mconductive\u001b[0m \u001b[93mpolyaniline\u001b[0m \u001b[92mconstructs\u001b[0m, and \u001b[93mphotocatalytic\u001b[0m \u001b[93mcarbon\u001b[0m \u001b[93mnitride\u001b[0m. \u001b[93mRepresentative\u001b[0m \u001b[93mcase\u001b[0m \u001b[93mstudies\u001b[0m are \u001b[93mdiscussed\u001b[0m to \u001b[93melucidate\u001b[0m \u001b[93mkey\u001b[0m \u001b[93mstructure\u001b[0m-\u001b[93mfunction\u001b[0m \u001b[93mrelationships\u001b[0m and \u001b[93mexperimentally\u001b[0m \u001b[93msupported\u001b[0m \u001b[93moutcomes\u001b[0m, \u001b[93mencompassing\u001b[0m \u001b[95mvalidated\u001b[0m in \u001b[93mvitro\u001b[0m and in \u001b[93mvivo\u001b[0m \u001b[93mfindings\u001b[0m \u001b[93macross\u001b[0m \u001b[93mantioxidant\u001b[0m, \u001b[93mtherapeutic\u001b[0m, and \u001b[93mdiagnostic\u001b[0m \u001b[92msystems\u001b[0m. This \u001b[93mcomparative\u001b[0m and \u001b[93mintegrative\u001b[0m \u001b[93mperspective\u001b[0m \u001b[93mestablishes\u001b[0m a \u001b[93mcohesive\u001b[0m \u001b[92mframework\u001b[0m for the \u001b[93mrational\u001b[0m \u001b[92mdesign\u001b[0m and \u001b[93mtranslational\u001b[0m \u001b[93mdevelopment\u001b[0m of \u001b[93mnext\u001b[0m-\u001b[93mgeneration\u001b[0m \u001b[93mMFNs\u001b[0m.\n- \u001b[93mInfluence\u001b[0m of \u001b[93mlaser\u001b[0m \u001b[93mpowder\u001b[0m \u001b[93mbed\u001b[0m \u001b[93mfusion\u001b[0m \u001b[93mbuild\u001b[0m \u001b[93morientation\u001b[0m on the \u001b[93mcorrosion\u001b[0m \u001b[93mresistance\u001b[0m of \u001b[93mCoCrWMo\u001b[0m \u001b[93malloy\u001b[0m \u001b[93mconsidering\u001b[0m \u001b[93mdislocation\u001b[0m \u001b[93mdensity\u001b[0m \u001b[93mcharacter\u001b[0m and \u001b[93mlattice\u001b[0m \u001b[93mmicrostrain\u001b[0m.: This \u001b[93mstudy\u001b[0m \u001b[95minvestigates\u001b[0m the \u001b[93mimpact\u001b[0m of \u001b[93mbuild\u001b[0m \u001b[93morientation\u001b[0m on the \u001b[93mcorrosion\u001b[0m \u001b[93mresistance\u001b[0m of \u001b[93mCoCrWMo\u001b[0m \u001b[93malloys\u001b[0m \u001b[93mfabricated\u001b[0m by \u001b[93mLaser\u001b[0m \u001b[93mPowder\u001b[0m \u001b[93mBed\u001b[0m \u001b[93mFusion\u001b[0m (\u001b[93mL\u001b[0m-\u001b[93mPBF\u001b[0m). \u001b[93mSamples\u001b[0m \u001b[93mprinted\u001b[0m at \u001b[93mangles\u001b[0m from \u001b[93m0\u001b[0m\u00b0 to \u001b[93m90\u001b[0m\u00b0 were \u001b[93mcharacterized\u001b[0m \u001b[93musing\u001b[0m \u001b[93mSEM\u001b[0m, \u001b[93mXRD\u001b[0m (with \u001b[93mmodified\u001b[0m \u001b[93mWilliamson\u001b[0m-\u001b[93mHall\u001b[0m and \u001b[93mWarren\u001b[0m-\u001b[93mAverbach\u001b[0m \u001b[93manalysis\u001b[0m), and \u001b[93mpotentiodynamic\u001b[0m \u001b[93mpolarization\u001b[0m in \u001b[93mRinger\u001b[0m'\u001b[93ms\u001b[0m \u001b[93msolution\u001b[0m. The \u001b[93mresults\u001b[0m \u001b[93mrevealed\u001b[0m that \u001b[93mbuild\u001b[0m \u001b[93morientation\u001b[0m \u001b[93mstrongly\u001b[0m \u001b[93maffects\u001b[0m \u001b[93mmicrostrain\u001b[0m, \u001b[93mdislocation\u001b[0m \u001b[93mdensity\u001b[0m, and \u001b[93mdislocation\u001b[0m \u001b[93mcharacter\u001b[0m, which in \u001b[93mturn\u001b[0m \u001b[33mgovern\u001b[0m \u001b[93mpassive\u001b[0m \u001b[93mlayer\u001b[0m \u001b[93mcomposition\u001b[0m and \u001b[93mcorrosion\u001b[0m \u001b[93mbehavior\u001b[0m. The \u001b[93msample\u001b[0m \u001b[93mprinted\u001b[0m at \u001b[93m90\u001b[0m\u00b0 \u001b[93mexhibited\u001b[0m the \u001b[93mhighest\u001b[0m \u001b[93mcorrosion\u001b[0m \u001b[93mresistance\u001b[0m, \u001b[93mcorrelating\u001b[0m with the \u001b[93mlowest\u001b[0m \u001b[93mdislocation\u001b[0m \u001b[93mdensity\u001b[0m, \u001b[93mminimal\u001b[0m \u001b[93mmicrostrain\u001b[0m, and the \u001b[93mhighest\u001b[0m \u001b[93mfraction\u001b[0m of \u001b[93mscrew\u001b[0m \u001b[93mdislocations\u001b[0m. \u001b[93mXPS\u001b[0m \u001b[93manalysis\u001b[0m \u001b[93mshowed\u001b[0m this \u001b[93msample\u001b[0m \u001b[93mhad\u001b[0m the \u001b[93mmost\u001b[0m \u001b[93mCr\u001b[0m-\u001b[93mrich\u001b[0m \u001b[93mpassive\u001b[0m \u001b[93mlayer\u001b[0m, with \u001b[93mCr\u2082O\u2083\u001b[0m \u001b[93maccounting\u001b[0m for over \u001b[93m60\u001b[0m% of \u001b[93moxide\u001b[0m \u001b[93mspecies\u001b[0m. In \u001b[93mcontrast\u001b[0m, \u001b[93mlow\u001b[0m-\u001b[93mangle\u001b[0m \u001b[93msamples\u001b[0m \u001b[93mexhibited\u001b[0m \u001b[93mmore\u001b[0m \u001b[93medge\u001b[0m \u001b[93mdislocations\u001b[0m, \u001b[93mhigher\u001b[0m \u001b[93mmicrostrain\u001b[0m, and \u001b[93mless\u001b[0m \u001b[93mprotective\u001b[0m \u001b[93moxide\u001b[0m \u001b[93mfilms\u001b[0m. These \u001b[93mfindings\u001b[0m \u001b[93mhighlight\u001b[0m the \u001b[93mcritical\u001b[0m \u001b[93mrole\u001b[0m of \u001b[93mbuild\u001b[0m-\u001b[93minduced\u001b[0m \u001b[93mcrystallographic\u001b[0m \u001b[93manisotropy\u001b[0m and \u001b[93mdefect\u001b[0m \u001b[93mstructure\u001b[0m in \u001b[93mshaping\u001b[0m \u001b[93mcorrosion\u001b[0m \u001b[93mresponse\u001b[0m in \u001b[93mL\u001b[0m-\u001b[93mPBF\u001b[0m-\u001b[93mprocessed\u001b[0m \u001b[93mbiomedical\u001b[0m \u001b[93malloys\u001b[0m. The \u001b[93mstudy\u001b[0m \u001b[93malso\u001b[0m \u001b[93mdemonstrates\u001b[0m the \u001b[93mutility\u001b[0m of \u001b[93madvanced\u001b[0m \u001b[93mXRD\u001b[0m-\u001b[93mbased\u001b[0m \u001b[93mmethods\u001b[0m for \u001b[93mquantifying\u001b[0m \u001b[93mlattice\u001b[0m \u001b[93mdistortions\u001b[0m and \u001b[93mdislocation\u001b[0m \u001b[93mpopulations\u001b[0m. \u001b[93mImportantly\u001b[0m, the \u001b[93mresults\u001b[0m \u001b[93msupport\u001b[0m \u001b[93msustainable\u001b[0m \u001b[92mdesign\u001b[0m \u001b[93mstrategies\u001b[0m by \u001b[93menhancing\u001b[0m \u001b[93mcorrosion\u001b[0m \u001b[93mresistance\u001b[0m through \u001b[93mprocess\u001b[0m \u001b[93mcontrol\u001b[0m, \u001b[93mreducing\u001b[0m \u001b[93mreliance\u001b[0m on \u001b[93mcoatings\u001b[0m or \u001b[93malloying\u001b[0m, and \u001b[93mpromoting\u001b[0m \u001b[93mresource\u001b[0m-\u001b[93mefficient\u001b[0m \u001b[93mmanufacturing\u001b[0m of \u001b[93mbiomedical\u001b[0m and \u001b[92mengineering\u001b[0m \u001b[93mcomponents\u001b[0m.\n- \u001b[93mParameter\u001b[0m \u001b[92mDesign\u001b[0m of \u001b[93mSand\u001b[0m \u001b[93mCasting\u001b[0m to \u001b[93mMinimize\u001b[0m \u001b[93mShrinkage\u001b[0m \u001b[93mDefects\u001b[0m, \u001b[93mPorosity\u001b[0m \u001b[93mDefects\u001b[0m and \u001b[93mIncomplete\u001b[0m \u001b[93mDefects\u001b[0m: \u001b[93mCasting\u001b[0m is \u001b[93mone\u001b[0m of the \u001b[93mmost\u001b[0m \u001b[93mcommonly\u001b[0m \u001b[93mused\u001b[0m \u001b[93mmanufacturing\u001b[0m \u001b[93mmethod\u001b[0m for \u001b[93mgeometrically\u001b[0m \u001b[93mcomplex\u001b[0m \u001b[93mproduct\u001b[0m. Among the \u001b[93mcasting\u001b[0m \u001b[93mtechnologies\u001b[0m, \u001b[93msand\u001b[0m \u001b[93mcasting\u001b[0m is \u001b[93moften\u001b[0m \u001b[93mfound\u001b[0m in \u001b[93mapplication\u001b[0m. \u001b[93mBeside\u001b[0m the \u001b[93madvantages\u001b[0m of the \u001b[93msand\u001b[0m-\u001b[93mcasting\u001b[0m \u001b[93mprocess\u001b[0m, it \u001b[93malso\u001b[0m \u001b[93mhas\u001b[0m a \u001b[93mdrawback\u001b[0m that is \u001b[93moften\u001b[0m \u001b[93mencountered\u001b[0m, \u001b[93mnamely\u001b[0m \u001b[93mproduct\u001b[0m \u001b[93mdefects\u001b[0m. \u001b[93mProduct\u001b[0m \u001b[93mdefects\u001b[0m \u001b[93mcan\u001b[0m be \u001b[93mcaused\u001b[0m by a \u001b[93mlack\u001b[0m of \u001b[93mattention\u001b[0m to \u001b[93msand\u001b[0m \u001b[93mcasting\u001b[0m \u001b[93mparameters\u001b[0m. This \u001b[93mwork\u001b[0m \u001b[93maims\u001b[0m to \u001b[93mminimize\u001b[0m those \u001b[93mdefects\u001b[0m, \u001b[93mincluding\u001b[0m \u001b[93mporosity\u001b[0m \u001b[93mdefects\u001b[0m, \u001b[93mshrinkage\u001b[0m \u001b[93mdefects\u001b[0m and \u001b[93mincomplete\u001b[0m \u001b[93mdefects\u001b[0m by \u001b[93moptimizing\u001b[0m \u001b[93mprocess\u001b[0m \u001b[93mparameters\u001b[0m \u001b[93musing\u001b[0m the \u001b[93mTaguchi\u001b[0m \u001b[93mmethod\u001b[0m. The \u001b[93midentified\u001b[0m \u001b[93msand\u001b[0m-\u001b[93mcasting\u001b[0m \u001b[93mprocess\u001b[0m \u001b[93mparameters\u001b[0m \u001b[93minclude\u001b[0m \u001b[93mgating\u001b[0m \u001b[93mlocation\u001b[0m, \u001b[93mriser\u001b[0m \u001b[93mlocation\u001b[0m, \u001b[93mmolding\u001b[0m \u001b[93mconditions\u001b[0m and \u001b[93mpouring\u001b[0m \u001b[93mtemperature\u001b[0m with \u001b[93meach\u001b[0m \u001b[93mparameter\u001b[0m \u001b[93mconsisting\u001b[0m of \u001b[93m3\u001b[0m \u001b[93mlevels\u001b[0m. This \u001b[93mresearch\u001b[0m \u001b[93musing\u001b[0m the \u001b[93mfractional\u001b[0m \u001b[93mfactorial\u001b[0m \u001b[93mL\u001b[0m \u001b[93m9\u001b[0m (\u001b[93m3\u001b[0m \u001b[93m4\u001b[0m ). \u001b[93mData\u001b[0m \u001b[93mprocessing\u001b[0m is \u001b[93mcarried\u001b[0m out by \u001b[93manalysis\u001b[0m of \u001b[93mmean\u001b[0m (\u001b[93mANOM\u001b[0m) to \u001b[93mobtain\u001b[0m \u001b[93mplot\u001b[0m \u001b[93meffects\u001b[0m. The \u001b[93mresults\u001b[0m \u001b[93mshowed\u001b[0m that the \u001b[93moptimal\u001b[0m \u001b[93mcombination\u001b[0m of \u001b[93mparameters\u001b[0m that \u001b[93mresulted\u001b[0m in \u001b[93mshrinkage\u001b[0m, \u001b[93mporosity\u001b[0m and \u001b[93mminimal\u001b[0m \u001b[93mincomplete\u001b[0m \u001b[93mdefects\u001b[0m were at \u001b[93mgating\u001b[0m \u001b[93mlocation\u001b[0m \u001b[93mlevel\u001b[0m \u001b[93m2\u001b[0m, \u001b[93mriser\u001b[0m \u001b[93mlocation\u001b[0m \u001b[93mlevel\u001b[0m \u001b[93m1\u001b[0m, \u001b[93mmold\u001b[0m \u001b[93mcondition\u001b[0m \u001b[93mlevel\u001b[0m \u001b[93m2\u001b[0m and \u001b[93mpouring\u001b[0m \u001b[93mtemperature\u001b[0m \u001b[93mlevel\u001b[0m \u001b[93m3\u001b[0m. The \u001b[93mresults\u001b[0m of the \u001b[93mcomparison\u001b[0m before and after \u001b[93moptimization\u001b[0m were an \u001b[93mincrease\u001b[0m of \u001b[93m0\u001b[0m.\u001b[93m77\u001b[0m, where \u001b[93mpreviously\u001b[0m it was \u001b[93m1\u001b[0m.\u001b[93m30\u001b[0m to \u001b[93m2\u001b[0m.\u001b[93m07\u001b[0m \u001b[93mbased\u001b[0m on \u001b[93mnormalized\u001b[0m \u001b[93mdata\u001b[0m.\n- \u001b[93mWriting\u001b[0m in \u001b[93mdefects\u001b[0m\n- \u001b[93mElectrophysiological\u001b[0m \u001b[95mdiagnosis\u001b[0m \u001b[93musing\u001b[0m the \u001b[93mcoefficient\u001b[0m of \u001b[93mvariation\u001b[0m of \u001b[93mR\u001b[0m-\u001b[93mR\u001b[0m \u001b[93mintervals\u001b[0m and a \u001b[93mpoint\u001b[0m-of-\u001b[93mcare\u001b[0m \u001b[93mnerve\u001b[0m \u001b[93mconduction\u001b[0m \u001b[93mdevice\u001b[0m is \u001b[93mhighly\u001b[0m \u001b[93mcorrelated\u001b[0m to the \u001b[95mdiagnosis\u001b[0m of \u001b[93mdiabetic\u001b[0m \u001b[93mpolyneuropathy\u001b[0m \u001b[93musing\u001b[0m \u001b[93mconventional\u001b[0m \u001b[93melectromyographs\u001b[0m.: \u001b[93mAims\u001b[0m/\u001b[93mintroduction\u001b[0m: While \u001b[93mtreatment\u001b[0m for \u001b[93mdiabetic\u001b[0m \u001b[93mpolyneuropathy\u001b[0m (\u001b[93mDPN\u001b[0m) is \u001b[93mstill\u001b[0m \u001b[93mdeveloping\u001b[0m, \u001b[93mprogress\u001b[0m \u001b[93mhas\u001b[0m \u001b[93mstagnated\u001b[0m. The \u001b[93malignment\u001b[0m between \u001b[93mpathological\u001b[0m \u001b[93mneurodegeneration\u001b[0m in \u001b[93mDPN\u001b[0m and \u001b[93mpatients\u001b[0m' \u001b[93msubjective\u001b[0m \u001b[93msymptoms\u001b[0m is \u001b[93moften\u001b[0m \u001b[93mlow\u001b[0m, \u001b[93myet\u001b[0m these \u001b[93msymptoms\u001b[0m are \u001b[93mfrequently\u001b[0m \u001b[93mused\u001b[0m for \u001b[95mdiagnosis\u001b[0m. This \u001b[93mreliance\u001b[0m \u001b[93mhas\u001b[0m \u001b[93mhindered\u001b[0m the \u001b[93mdevelopment\u001b[0m of \u001b[93meffective\u001b[0m \u001b[93mdrugs\u001b[0m to \u001b[93mprevent\u001b[0m \u001b[93mneurodegeneration\u001b[0m. This \u001b[93mstudy\u001b[0m \u001b[93maims\u001b[0m to \u001b[93mestablish\u001b[0m an \u001b[93mobjective\u001b[0m \u001b[93melectrophysiological\u001b[0m \u001b[93mdiagnostic\u001b[0m \u001b[93mmethod\u001b[0m that \u001b[93mcould\u001b[0m \u001b[93msupport\u001b[0m \u001b[93mfuture\u001b[0m \u001b[93mtreatment\u001b[0m \u001b[93mdevelopment\u001b[0m and \u001b[95mvalidate\u001b[0m its \u001b[93maccuracy\u001b[0m. \u001b[93mMaterials\u001b[0m and \u001b[93mmethods\u001b[0m: This \u001b[93mretrospective\u001b[0m \u001b[93mmulticenter\u001b[0m \u001b[93mcohort\u001b[0m \u001b[93mstudy\u001b[0m \u001b[93minvolved\u001b[0m \u001b[93mhospitalized\u001b[0m \u001b[93mdiabetic\u001b[0m \u001b[93mpatients\u001b[0m. A \u001b[93mtotal\u001b[0m of \u001b[93m314\u001b[0m \u001b[93mpatients\u001b[0m \u001b[93munderwent\u001b[0m \u001b[93mnerve\u001b[0m \u001b[93mconduction\u001b[0m \u001b[93mstudies\u001b[0m \u001b[93musing\u001b[0m \u001b[93mstandard\u001b[0m \u001b[93melectromyography\u001b[0m and a \u001b[93msimplified\u001b[0m \u001b[93mnerve\u001b[0m \u001b[93mconduction\u001b[0m \u001b[93mtesting\u001b[0m \u001b[93mdevice\u001b[0m (\u001b[93mNC\u001b[0m-\u001b[93mstat\u001b[0m/\u001b[93mDPNCheck\u001b[0m\u2122), \u001b[93malong\u001b[0m with \u001b[93melectrocardiogram\u001b[0m-\u001b[93mbased\u001b[0m \u001b[93mcoefficient\u001b[0m of \u001b[93mvariation\u001b[0m of \u001b[93mR\u001b[0m-\u001b[93mR\u001b[0m \u001b[93mintervals\u001b[0m (\u001b[93mCV\u001b[0m \u001b[93mR\u001b[0m-\u001b[93mR\u001b[0m ). \u001b[93mPatients\u001b[0m with a \u001b[93mseverity\u001b[0m \u001b[93mclassification\u001b[0m of \u001b[93mStage\u001b[0m \u001b[93m2\u001b[0m or \u001b[93mhigher\u001b[0m \u001b[93mbased\u001b[0m on \u001b[93melectromyography\u001b[0m were \u001b[93mdefined\u001b[0m as \u001b[93mhaving\u001b[0m \u001b[93mDPN\u001b[0m. \u001b[93mLogistic\u001b[0m \u001b[93mregression\u001b[0m \u001b[93manalysis\u001b[0m was \u001b[93mused\u001b[0m to \u001b[93midentify\u001b[0m \u001b[93msignificant\u001b[0m \u001b[93mfactors\u001b[0m \u001b[93mexplaining\u001b[0m \u001b[93mDPN\u001b[0m \u001b[93mpresence\u001b[0m, \u001b[93mfollowed\u001b[0m by \u001b[93mROC\u001b[0m \u001b[93manalysis\u001b[0m to \u001b[93mdetermine\u001b[0m \u001b[93moptimal\u001b[0m \u001b[93mcutoff\u001b[0m \u001b[93mvalues\u001b[0m for \u001b[95mdiagnosis\u001b[0m. \u001b[93mResults\u001b[0m: \u001b[93mSignificant\u001b[0m \u001b[93mfactors\u001b[0m \u001b[93mincluded\u001b[0m \u001b[93mresting\u001b[0m \u001b[93mCV\u001b[0m \u001b[93mR\u001b[0m-\u001b[93mR\u001b[0m , \u001b[93msural\u001b[0m \u001b[93mnerve\u001b[0m \u001b[93mconduction\u001b[0m \u001b[93mvelocity\u001b[0m (\u001b[93mSNCV\u001b[0m), and \u001b[93mamplitude\u001b[0m of \u001b[93msensory\u001b[0m \u001b[93mnerve\u001b[0m \u001b[93maction\u001b[0m \u001b[93mpotential\u001b[0m (\u001b[93mSNAP\u001b[0m). \u001b[93mSNCV\u001b[0m \u001b[93mhad\u001b[0m the \u001b[93mhighest\u001b[0m \u001b[93marea\u001b[0m under the \u001b[93mcurve\u001b[0m (\u001b[93mAUC\u001b[0m = \u001b[93m0\u001b[0m.\u001b[93m823\u001b[0m). The \u001b[93moptimal\u001b[0m \u001b[93mcutoff\u001b[0m \u001b[93mvalues\u001b[0m were \u001b[93m1\u001b[0m.\u001b[93m62\u001b[0m% for \u001b[93mCV\u001b[0m \u001b[93mR\u001b[0m-\u001b[93mR\u001b[0m , \u001b[93m46\u001b[0m.\u001b[93m5\u001b[0m \u001b[93mm\u001b[0m/\u001b[93ms\u001b[0m for \u001b[93mSNCV\u001b[0m, and \u001b[93m10\u001b[0m.\u001b[93m5\u001b[0m \u001b[93m\u03bcV\u001b[0m for \u001b[93mSNAP\u001b[0m. \u001b[93mDiagnosing\u001b[0m \u001b[93mDPN\u001b[0m \u001b[93mbased\u001b[0m on \u001b[93mabnormalities\u001b[0m in \u001b[93mtwo\u001b[0m or \u001b[93mmore\u001b[0m of these \u001b[93mthree\u001b[0m \u001b[93mconditions\u001b[0m \u001b[93myielded\u001b[0m an \u001b[93maccuracy\u001b[0m of \u001b[93m79\u001b[0m.\u001b[93m3\u001b[0m%. \u001b[93mConclusions\u001b[0m: The \u001b[93mestablished\u001b[0m \u001b[93mdiagnostic\u001b[0m \u001b[93mcriteria\u001b[0m of \u001b[93mDPN\u001b[0m \u001b[93mdemonstrate\u001b[0m \u001b[93mhigh\u001b[0m \u001b[93mperformance\u001b[0m and are \u001b[93mexpected\u001b[0m to be \u001b[93mapplicable\u001b[0m in \u001b[93mclinical\u001b[0m \u001b[93msettings\u001b[0m.\n- \u001b[93mDefects\u001b[0m in \u001b[93mthree\u001b[0m-\u001b[93mdimensions\u001b[0m\n- \u001b[93mLong\u001b[0m-\u001b[93mTerm\u001b[0m \u001b[93mClinical\u001b[0m \u001b[93mOutcomes\u001b[0m for \u001b[93mSingle\u001b[0m \u001b[93mDental\u001b[0m \u001b[93mCrowns\u001b[0m \u001b[93mversus\u001b[0m \u001b[93mExtensive\u001b[0m \u001b[93mDirect\u001b[0m \u001b[93mRestorations\u001b[0m: A \u001b[93mRegister\u001b[0m-\u001b[93mBased\u001b[0m \u001b[93mCohort\u001b[0m \u001b[93mStudy\u001b[0m with up to \u001b[93m10\u001b[0m \u001b[93mYears\u001b[0m of \u001b[93mFollow\u001b[0m-Up in a \u001b[93mSwedish\u001b[0m \u001b[93mPopulation\u001b[0m.: \u001b[93mObjective\u001b[0m: \u001b[93mThere\u001b[0m is a \u001b[93mlack\u001b[0m of \u001b[93mconsensus\u001b[0m \u001b[93mregarding\u001b[0m the \u001b[93moptimal\u001b[0m \u001b[93mmethod\u001b[0m for \u001b[93mrestoring\u001b[0m \u001b[93mteeth\u001b[0m with \u001b[93mextensive\u001b[0m \u001b[93mdefects\u001b[0m. In \u001b[93mparticular\u001b[0m, it'\u001b[93ms\u001b[0m not \u001b[93mclear\u001b[0m \u001b[93mwhether\u001b[0m a \u001b[93mdirect\u001b[0m \u001b[93mrestoration\u001b[0m (\u001b[93mtooth\u001b[0m \u001b[93mfilling\u001b[0m) \u001b[93mcan\u001b[0m \u001b[93machieve\u001b[0m \u001b[93mcomparable\u001b[0m \u001b[93mtooth\u001b[0m \u001b[93msurvival\u001b[0m \u001b[93mrates\u001b[0m to a \u001b[93mdental\u001b[0m \u001b[93mcrown\u001b[0m (\u001b[93mindirect\u001b[0m \u001b[93mrestoration\u001b[0m). This \u001b[93mstudy\u001b[0m \u001b[93mcompares\u001b[0m the \u001b[93msurvival\u001b[0m \u001b[93mrates\u001b[0m with up to \u001b[93m10\u001b[0m \u001b[93myears\u001b[0m \u001b[93mpost\u001b[0m-\u001b[93mintervention\u001b[0m for \u001b[93mlarge\u001b[0m \u001b[93mdirect\u001b[0m \u001b[93mrestorations\u001b[0m (\u001b[93mfillings\u001b[0m \u001b[93minvolving\u001b[0m \u001b[93mthree\u001b[0m or \u001b[93mmore\u001b[0m \u001b[93msurfaces\u001b[0m) with those of \u001b[93mindirect\u001b[0m \u001b[93mrestorations\u001b[0m (\u001b[93msingle\u001b[0m \u001b[93mcrowns\u001b[0m), \u001b[93musing\u001b[0m a \u001b[93mlarge\u001b[0m \u001b[93mdataset\u001b[0m. \u001b[93mMethods\u001b[0m: \u001b[93mAll\u001b[0m \u001b[93mpatients\u001b[0m (\u001b[93mN\u001b[0m = \u001b[93m189\u001b[0m,\u001b[93m195\u001b[0m) who \u001b[93mreceived\u001b[0m \u001b[93meither\u001b[0m \u001b[93msingle\u001b[0m \u001b[93mcrowns\u001b[0m (\u001b[93mindirect\u001b[0m \u001b[93mrestorations\u001b[0m) or \u001b[93mdirect\u001b[0m \u001b[93mrestorations\u001b[0m (\u001b[93minvolving\u001b[0m \u001b[93mthree\u001b[0m or \u001b[93mmore\u001b[0m \u001b[93msurfaces\u001b[0m) between \u001b[93m2014\u001b[0m and \u001b[93m2019\u001b[0m in the \u001b[93mpublic\u001b[0m \u001b[93mdental\u001b[0m \u001b[93mclinics\u001b[0m of a \u001b[93mSwedish\u001b[0m \u001b[93mregion\u001b[0m were \u001b[93mfollowed\u001b[0m \u001b[93mretrospectively\u001b[0m for a \u001b[93mperiod\u001b[0m of \u001b[93m5\u001b[0m to \u001b[93m10\u001b[0m \u001b[93myears\u001b[0m (\u001b[93mN\u001b[0m: \u001b[93m343\u001b[0m,\u001b[93m809\u001b[0m \u001b[93mteeth\u001b[0m). \u001b[93mOutcome\u001b[0m \u001b[93mmeasures\u001b[0m \u001b[93mincluded\u001b[0m \u001b[93mtooth\u001b[0m \u001b[93mextraction\u001b[0m, \u001b[93mroot\u001b[0m \u001b[93mcanal\u001b[0m \u001b[93mtreatment\u001b[0m, and \u001b[93mretreatment\u001b[0m with \u001b[93meither\u001b[0m \u001b[93mdirect\u001b[0m or \u001b[93mindirect\u001b[0m \u001b[93mrestorations\u001b[0m. \u001b[93mResults\u001b[0m: The \u001b[93m10\u001b[0m-\u001b[93myear\u001b[0m \u001b[93mcumulative\u001b[0m \u001b[93msurvival\u001b[0m \u001b[93mrates\u001b[0m were \u001b[93m92\u001b[0m,\u001b[93m77\u001b[0m% for \u001b[93mindirect\u001b[0m \u001b[93mrestorations\u001b[0m and \u001b[93m89\u001b[0m,\u001b[93m09\u001b[0m% for \u001b[93mdirect\u001b[0m \u001b[93mrestorations\u001b[0m. \u001b[93mDirect\u001b[0m \u001b[93mrestorations\u001b[0m were \u001b[93massociated\u001b[0m with a \u001b[93msignificantly\u001b[0m \u001b[93mgreater\u001b[0m \u001b[93mneed\u001b[0m for \u001b[93mretreatment\u001b[0m during the \u001b[93m10\u001b[0m-\u001b[93myear\u001b[0m \u001b[93mperiod\u001b[0m \u001b[93mcompared\u001b[0m to \u001b[93mindirect\u001b[0m \u001b[93mrestorations\u001b[0m. The \u001b[93mincidence\u001b[0m \u001b[93mrate\u001b[0m \u001b[93mratio\u001b[0m (\u001b[93mIRR\u001b[0m) for \u001b[93mdirect\u001b[0m \u001b[93mrestorations\u001b[0m was \u001b[93m1\u001b[0m.\u001b[93m59\u001b[0m (\u001b[93m95\u001b[0m% \u001b[93mCI\u001b[0m \u001b[93m1\u001b[0m.\u001b[93m578\u001b[0m-\u001b[93m1\u001b[0m.\u001b[93m611\u001b[0m) \u001b[93mrelative\u001b[0m to \u001b[93mindirect\u001b[0m \u001b[93mrestorations\u001b[0m. \u001b[93mPrevious\u001b[0m \u001b[93mroot\u001b[0m \u001b[93mcanal\u001b[0m \u001b[93mtreatment\u001b[0m or the \u001b[93mpresence\u001b[0m of a \u001b[93mpost\u001b[0m and \u001b[93mcore\u001b[0m \u001b[93msignificantly\u001b[0m \u001b[93mincreased\u001b[0m the \u001b[93mrisk\u001b[0m of \u001b[93mextraction\u001b[0m, with \u001b[93mhazard\u001b[0m \u001b[93mratios\u001b[0m of \u001b[93m2\u001b[0m.\u001b[93m90\u001b[0m (\u001b[93m95\u001b[0m% \u001b[93mCI\u001b[0m \u001b[93m2\u001b[0m.\u001b[93m8389\u001b[0m-\u001b[93m2\u001b[0m.\u001b[93m9824\u001b[0m) and \u001b[93m1\u001b[0m.\u001b[93m40\u001b[0m (\u001b[93m95\u001b[0m% \u001b[93mCI\u001b[0m \u001b[93m1\u001b[0m.\u001b[93m3269\u001b[0m-\u001b[93m1\u001b[0m.\u001b[93m4928\u001b[0m), \u001b[93mrespectively\u001b[0m. \u001b[93mConclusion\u001b[0m: \u001b[93mTeeth\u001b[0m \u001b[93mrestored\u001b[0m with \u001b[93mlarge\u001b[0m \u001b[93mdirect\u001b[0m \u001b[93mrestorations\u001b[0m \u001b[93mtended\u001b[0m to \u001b[93mrequire\u001b[0m \u001b[93mmore\u001b[0m \u001b[93mfrequent\u001b[0m \u001b[93mretreatments\u001b[0m and \u001b[93mshowed\u001b[0m a \u001b[93mhigher\u001b[0m \u001b[93mrisk\u001b[0m of \u001b[93mextraction\u001b[0m over a \u001b[93mperiod\u001b[0m of up to \u001b[93m10\u001b[0m \u001b[93myears\u001b[0m \u001b[93mcompared\u001b[0m with \u001b[93mteeth\u001b[0m \u001b[93mrestored\u001b[0m with \u001b[93mindirect\u001b[0m \u001b[93mrestorations\u001b[0m. This \u001b[93mtrend\u001b[0m was \u001b[93mparticularly\u001b[0m \u001b[93mevident\u001b[0m among \u001b[93mnon\u001b[0m-\u001b[93mvital\u001b[0m \u001b[93mteeth\u001b[0m, \u001b[93mespecially\u001b[0m those with a \u001b[93mpost\u001b[0m and \u001b[93mcore\u001b[0m or \u001b[93mprevious\u001b[0m \u001b[93mroot\u001b[0m \u001b[93mcanal\u001b[0m \u001b[93mtreatment\u001b[0m. \u001b[93mHowever\u001b[0m, \u001b[93mdue\u001b[0m to the \u001b[93mretrospective\u001b[0m \u001b[92mdesign\u001b[0m and \u001b[93mpotential\u001b[0m \u001b[93minclusion\u001b[0m \u001b[93mbias\u001b[0m, these \u001b[93mfindings\u001b[0m \u001b[93mshould\u001b[0m be \u001b[93minterpreted\u001b[0m with \u001b[93mcaution\u001b[0m. \u001b[93mClinical\u001b[0m \u001b[93msignificance\u001b[0m: Within the \u001b[93mlimitations\u001b[0m of this \u001b[93mretrospective\u001b[0m, \u001b[93mnon\u001b[0m-\u001b[93mrandomized\u001b[0m \u001b[93mstudy\u001b[0m, \u001b[93mteeth\u001b[0m \u001b[93mrestored\u001b[0m with \u001b[93mlarge\u001b[0m \u001b[93mdirect\u001b[0m \u001b[93mrestorations\u001b[0m \u001b[93mappeared\u001b[0m to \u001b[93mhave\u001b[0m \u001b[93mslightly\u001b[0m \u001b[93mlower\u001b[0m \u001b[93mlong\u001b[0m-\u001b[93mterm\u001b[0m \u001b[93msurvival\u001b[0m and a \u001b[93msomewhat\u001b[0m \u001b[93mhigher\u001b[0m \u001b[93mneed\u001b[0m for \u001b[93mretreatment\u001b[0m than \u001b[93mteeth\u001b[0m \u001b[93mrestored\u001b[0m with \u001b[93mcrowns\u001b[0m. Because \u001b[93mtreatment\u001b[0m \u001b[93mselection\u001b[0m was \u001b[93mbased\u001b[0m on \u001b[93mclinical\u001b[0m \u001b[93mjudgment\u001b[0m and \u001b[93mtooth\u001b[0m \u001b[93mcondition\u001b[0m \u001b[93mrather\u001b[0m than \u001b[93mrandom\u001b[0m \u001b[93mallocation\u001b[0m, the \u001b[93mobserved\u001b[0m \u001b[93mdifferences\u001b[0m \u001b[93mlikely\u001b[0m \u001b[93mreflect\u001b[0m \u001b[93mboth\u001b[0m \u001b[93mtreatment\u001b[0m \u001b[93mchoice\u001b[0m and \u001b[93mcase\u001b[0m \u001b[93mcomplexity\u001b[0m. \u001b[93mFuture\u001b[0m \u001b[93mstudies\u001b[0m \u001b[93musing\u001b[0m \u001b[93mmatched\u001b[0m \u001b[93mcohorts\u001b[0m or \u001b[93mrandomized\u001b[0m \u001b[92mdesigns\u001b[0m are \u001b[93mneeded\u001b[0m to \u001b[93mclarify\u001b[0m the \u001b[93mcausal\u001b[0m \u001b[93mrelationship\u001b[0m between \u001b[93mrestoration\u001b[0m \u001b[93mtype\u001b[0m and \u001b[93mlong\u001b[0m-\u001b[93mterm\u001b[0m \u001b[93mtooth\u001b[0m \u001b[93msurvival\u001b[0m.\n- \u001b[93mMulti\u001b[0m-\u001b[93mhit\u001b[0m \u001b[93mTP53\u001b[0m \u001b[93mconfers\u001b[0m the \u001b[93mpoorest\u001b[0m \u001b[93msurvival\u001b[0m in \u001b[93mmultiple\u001b[0m \u001b[93mmyeloma\u001b[0m in the \u001b[93mera\u001b[0m of \u001b[93mnovel\u001b[0m \u001b[93mtherapies\u001b[0m.: \u001b[93mMultiple\u001b[0m \u001b[93mmyeloma\u001b[0m (\u001b[93mMM\u001b[0m) with \u001b[93mhigh\u001b[0m-\u001b[93mrisk\u001b[0m (\u001b[93mHR\u001b[0m) \u001b[93mgenetic\u001b[0m \u001b[93mabnormalities\u001b[0m \u001b[93mhas\u001b[0m \u001b[93mpoor\u001b[0m \u001b[93mprognosis\u001b[0m, \u001b[93mdespite\u001b[0m the \u001b[93muse\u001b[0m of \u001b[93mnovel\u001b[0m \u001b[93mtherapeutic\u001b[0m \u001b[93magents\u001b[0m. \u001b[93mHowever\u001b[0m, the \u001b[93mindividual\u001b[0m \u001b[93mcontribution\u001b[0m of \u001b[93mspecific\u001b[0m \u001b[93mHR\u001b[0m \u001b[93mgenetic\u001b[0m \u001b[93mabnormalities\u001b[0m or \u001b[93mtheir\u001b[0m \u001b[93mco\u001b[0m-\u001b[93moccurrence\u001b[0m to \u001b[93mpoor\u001b[0m \u001b[93moutcomes\u001b[0m, \u001b[93mespecially\u001b[0m in the \u001b[93mera\u001b[0m of \u001b[93mnovel\u001b[0m \u001b[93magents\u001b[0m, \u001b[93mremains\u001b[0m \u001b[93munclear\u001b[0m. This \u001b[93mstudy\u001b[0m \u001b[93mevaluated\u001b[0m the \u001b[93mimpact\u001b[0m of \u001b[93mmulti\u001b[0m-\u001b[93mhit\u001b[0m \u001b[93mTP53\u001b[0m (\u001b[93mdel\u001b[0m(\u001b[93m17p\u001b[0m) and \u001b[93mTP53\u001b[0m \u001b[91mmutation\u001b[0m or \u2265 \u001b[93m2\u001b[0m \u001b[93mTP53\u001b[0m \u001b[91mmutations\u001b[0m) \u001b[93mcompared\u001b[0m with \u001b[93mother\u001b[0m \u001b[93mHR\u001b[0m \u001b[93mabnormalities\u001b[0m on \u001b[93mprogression\u001b[0m-\u001b[93mfree\u001b[0m \u001b[93msurvival\u001b[0m (\u001b[93mPFS\u001b[0m), \u001b[93moverall\u001b[0m \u001b[93msurvival\u001b[0m (\u001b[93mOS\u001b[0m) and \u001b[93mblood\u001b[0m \u001b[93msignature\u001b[0m in a \u001b[93mreal\u001b[0m-\u001b[93mworld\u001b[0m \u001b[93mcohort\u001b[0m of \u001b[93m204\u001b[0m \u001b[93mpatients\u001b[0m with \u001b[93mMM\u001b[0m \u001b[93mtreated\u001b[0m with \u001b[93mnovel\u001b[0m \u001b[93magents\u001b[0m (\u001b[93mmedian\u001b[0m \u001b[93mfollow\u001b[0m-up \u001b[93m28\u001b[0m \u001b[93mmonths\u001b[0m). \u001b[93mPatients\u001b[0m with \u001b[93mmulti\u001b[0m-\u001b[93mhit\u001b[0m \u001b[93mTP53\u001b[0m (\u001b[93m10\u001b[0m.\u001b[93m4\u001b[0m%) \u001b[93mhad\u001b[0m the \u001b[93mshortest\u001b[0m \u001b[93mPFS\u001b[0m and \u001b[93mOS\u001b[0m \u001b[93mcompared\u001b[0m with those with \u001b[93msingle\u001b[0m \u001b[93mHR\u001b[0m \u001b[93mabnormalities\u001b[0m (\u001b[93mp\u001b[0m \u2264 \u001b[93m0\u001b[0m.\u001b[93m011\u001b[0m) or with \u001b[93mco\u001b[0m-\u001b[93moccurrence\u001b[0m of \u2265 \u001b[93m2\u001b[0m \u001b[93mother\u001b[0m \u001b[93mHR\u001b[0m \u001b[93mabnormalities\u001b[0m (\u001b[93mp\u001b[0m \u2264 \u001b[93m0\u001b[0m.\u001b[93m002\u001b[0m), \u001b[93mregardless\u001b[0m of \u001b[93mtherapy\u001b[0m \u001b[93mline\u001b[0m. The \u001b[93mrelative\u001b[0m \u001b[93mrisk\u001b[0m of \u001b[93mearly\u001b[0m \u001b[93mprogression\u001b[0m in \u001b[93mpatients\u001b[0m with \u001b[93mmulti\u001b[0m-\u001b[93mhit\u001b[0m \u001b[93mTP53\u001b[0m was \u001b[93malmost\u001b[0m \u001b[93mthree\u001b[0m \u001b[93mtimes\u001b[0m \u001b[93mhigher\u001b[0m than that of \u001b[93mpatients\u001b[0m with \u001b[93mother\u001b[0m \u001b[93mHR\u001b[0m \u001b[93mabnormalities\u001b[0m. The \u001b[93mprevalence\u001b[0m of \u001b[93mTP53\u001b[0m \u001b[93malterations\u001b[0m \u001b[93mincreased\u001b[0m in \u001b[93mlater\u001b[0m \u001b[93mdisease\u001b[0m \u001b[93mstages\u001b[0m: \u001b[93mmulti\u001b[0m-\u001b[93mhit\u001b[0m \u001b[93mTP53\u001b[0m was \u001b[93mdetected\u001b[0m in \u001b[93m7\u001b[0m.\u001b[93m6\u001b[0m% of \u001b[93mpatients\u001b[0m with \u2264 \u001b[93m1\u001b[0m \u001b[93mprior\u001b[0m \u001b[93mtherapy\u001b[0m \u001b[93mline\u001b[0m and in \u001b[93m36\u001b[0m.\u001b[93m4\u001b[0m% of \u001b[93mpatients\u001b[0m with \u2265 \u001b[93m2\u001b[0m \u001b[93mprior\u001b[0m \u001b[93mlines\u001b[0m. \u001b[93mPatients\u001b[0m with \u001b[93mmulti\u001b[0m-\u001b[93mhit\u001b[0m \u001b[93mTP53\u001b[0m \u001b[93malso\u001b[0m \u001b[93mdiffered\u001b[0m in \u001b[93mblood\u001b[0m \u001b[93msignature\u001b[0m, \u001b[93mparticularly\u001b[0m in \u001b[93mcounts\u001b[0m of \u001b[93mwhite\u001b[0m \u001b[93mblood\u001b[0m \u001b[93mcells\u001b[0m, \u001b[93mlymphocytes\u001b[0m, \u001b[93mserum\u001b[0m \u001b[93mcreatinine\u001b[0m and \u001b[93m\u03b22\u001b[0m-\u001b[93mmicroglobulin\u001b[0m \u001b[93mlevels\u001b[0m \u001b[93mcompared\u001b[0m with those with \u001b[93mother\u001b[0m \u001b[93mHR\u001b[0m \u001b[93mabnormalities\u001b[0m. In \u001b[93mconclusion\u001b[0m, \u001b[93mmulti\u001b[0m-\u001b[93mhit\u001b[0m \u001b[93mTP53\u001b[0m is \u001b[93massociated\u001b[0m with the \u001b[93mpoorest\u001b[0m \u001b[93msurvival\u001b[0m among \u001b[93mall\u001b[0m \u001b[93mHR\u001b[0m \u001b[93msubgroups\u001b[0m in \u001b[93mMM\u001b[0m. \u001b[93mConsidering\u001b[0m that \u001b[93mTP53\u001b[0m \u001b[93malterations\u001b[0m \u001b[93maccumulate\u001b[0m during \u001b[93mMM\u001b[0m \u001b[93mprogression\u001b[0m and are \u001b[93massociated\u001b[0m with \u001b[93mdrug\u001b[0m \u001b[93mresistance\u001b[0m even in the \u001b[93mcontext\u001b[0m of \u001b[93mnovel\u001b[0m \u001b[93mtherapies\u001b[0m, \u001b[93mour\u001b[0m \u001b[93mstudy\u001b[0m \u001b[93mfurther\u001b[0m \u001b[93memphasizes\u001b[0m the \u001b[93mneed\u001b[0m for \u001b[93mroutine\u001b[0m \u001b[93mevaluation\u001b[0m of \u001b[93mboth\u001b[0m \u001b[93mdel\u001b[0m(\u001b[93m17p\u001b[0m) and \u001b[93mTP53\u001b[0m \u001b[91mmutations\u001b[0m. \u001b[93mPatients\u001b[0m with \u001b[93mmulti\u001b[0m-\u001b[93mhit\u001b[0m \u001b[93mTP53\u001b[0m \u001b[93mshould\u001b[0m be \u001b[93mprioritized\u001b[0m for \u001b[93minclusion\u001b[0m in \u001b[93mtrials\u001b[0m of \u001b[93mnovel\u001b[0m \u001b[93mtherapeutic\u001b[0m \u001b[93mstrategies\u001b[0m.\n- \u001b[93mSounding\u001b[0m out \u001b[93mdefects\u001b[0m"
}